Pregnancy. Teratogenic Effects: Pregnancy Category C. In reproductive toxicity studies in rats and rabbits, oral treatment with sumatriptan was associated with embryolethality, fetal abnormalities, and pup mortality.
Studies on triptan (pregnancy category C) use during pregnancy has been fairly reassuring. For pregnancies where triptan use is needed, sumatriptan (Imitrex) is usually the first triptan to be prescribed. Sumatriptan has been available longest and has the most safety data.
Pregnancy: Pregnancy Category C: Sumatriptan has been shown to be embryolethal in rabbits when given daily at a dose approximately
by CD LOGEMANN 2024 Cited by 11Sumatriptan is listed as a pregnancy category C medication. If sumatriptan is prescribed during pregnancy, health professionals should contact
sodium (TreximetTM) are assigned FDA Pregnancy Category C status, a total of 673 pregnancy exposures to sumatriptan, naratriptan, and/or Treximet with
Advice and warnings for the use of Sumatriptan during pregnancy. FDA Pregnancy Category C - Risk cannot be ruled out.
There are currently seven oral triptans on the market in the United States: sumatriptan (Imitrex), Triptans are considered category C in pregnancy, so the
primary headache during pregnancy, but use during pregnancy outside the Sumatriptan. Naratriptan. Migraine. -. - ? (I). Sumatriptan. Sumatriptan .
pregnancy outcomes in approximately 1,100 women exposed to sumatriptan The Use of SUMATRIPTAN During Pregnancy: Do not use SUMATRIPTAN if
Comments